The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
Open accessAbstract
The application of DNA technology to regulate the transcription of disease-related genes in vivo has important therapeutic potentials. The transcription factor E2F plays a pivotal role in the coordinated transactivation of cell cycle-regulatory genes such as c-myc, cdc2, and the gene encoding proliferating-cell nuclear antigen (PCNA) that are involved in lesion formation after vascular injury. We hypothesized that double-stranded DNA with high affinity for E2F may be introduced in vivo as a decoy to bind E2F and block the activation of genes mediating cell cycle progression and intimal hyperplasia after vascular injury. Gel mobility-shift assays showed complete competition for E2F binding protein by the E2F decoy. Transfection with E2F decoy inhibited expression of c-myc, cdc2, and the PCNA gene as well as vascular smooth muscle cell proliferation both in vitro and in the in vivo model of rat carotid injury. Furthermore, 2 weeks after in vivo transfection, neointimal formation was significantly prevented by the E2F decoy, and this inhibition continued up to 8 weeks after a single transfection in a dose-dependent manner. Transfer of an E2F decoy can therefore modulate gene expression and inhibit smooth muscle proliferation and vascular lesion formation in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Emerging Concept of Vascular Remodeling
Epstein, F. H., Gibbons, G. H., & Dzau, V. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405193302008 · Cited by 1,575
Self-citationE2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
Kaelin, W. G., Krek, W., Sellers, W. R., DeCaprio, J. A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T., Li, Y., Farnham, P. J., Blanar, M. A., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90108-o · Cited by 819
Retinoblastoma protein switches the E2F site from positive to negative element
Weintraub, S. J., Prater, C. A., & Dean, D. C. (1992) · Nature · doi:10.1038/358259a0 · Cited by 657
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E., & Fattaey, A. (1992) · Cell · doi:10.1016/0092-8674(92)90107-n · Cited by 613
Identification of a cellular transcription factor involved in E1A trans-activation
Kovesdi, I., Reichel, R., & Nevins, J. R. (1986) · Cell · doi:10.1016/0092-8674(86)90386-7 · Cited by 540
Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T., & Dzau, V. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8474 · Cited by 458
Self-citationOverexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
Sullenger, B. A., Gallardo, H. F., Ungers, G. E., & Gilboa, E. (1990) · Cell · doi:10.1016/0092-8674(90)90455-n · Cited by 443
Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90559-h · Cited by 407
Migration of smooth muscle and endothelial cells. Critical events in restenosis.
Casscells, W. (1992) · Circulation · doi:10.1161/01.cir.86.3.723 · Cited by 399
Cell cycle regulation of the human cdc2 gene.
Dalton, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05231.x · Cited by 381
Regulation of Gene Expression with Double-Stranded Phosphorothioate Oligonucleotides
Bielinska, A., Shivdasani, R. A., Zhang, L., & Nabel, G. J. (1990) · Science · doi:10.1126/science.2237444 · Cited by 372
Self-citationClinical trials of restenosis after coronary angioplasty.
Popma, J. J., Califf, R. M., & Topol, E. J. (1991) · Circulation · doi:10.1161/01.cir.84.3.1426 · Cited by 334
Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia.
Montalescot, G., Faraggi, M., Drobinski, G., Messian, O., Evans, J., Grosgogeat, Y., & Thomas, D. (1992) · Circulation · doi:10.1161/01.cir.86.1.47 · Cited by 276
E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.
Hiebert, S. W., Lipp, M., & Nevins, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3594 · Cited by 274
Thalmeier, K., Synovzik, H., Mertz, R., Winnacker, E. L., & Lipp, M. (1989) · Genes & Development · doi:10.1101/gad.3.4.527 · Cited by 245
Klein-Hitpass, L., Tsai, S. Y., Weigel, N. L., Allan, G. F., Riley, D., Rodriguez, R., Schrader, W. T., Tsai, M.-L., & O'Malley, B. W. (1990) · Cell · doi:10.1016/0092-8674(90)90740-6 · Cited by 212
Yee, A. S., Reichel, R. R., Kovesdi, I., & Nevins, J. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02471.x · Cited by 135
Novel and effective gene transfer technique for study of vascular renin angiotensin system.
Morishita, R., Gibbons, G. H., Kaneda, Y., Ogihara, T., & Dzau, V. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116496 · Cited by 105
Self-citationHoriuchi, M., Nakamura, N., Tang, S. S., Barrett, G. L., & Dzau, V. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98542-x · Cited by 58
Self-citationWagner, S., & Green, M. R. (1991) · Nature · doi:10.1038/352189a0 · Cited by 58
Cited by
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
Dzau, V. J., Braun-Dullaeus, R. C., & Sedding, D. G. (2002) · Nature Medicine · doi:10.1038/nm1102-1249 · Cited by 831
Self-citationAptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach
Fang, X., & Tan, W. (2010) · Accounts of Chemical Research · doi:10.1021/ar900101s · Cited by 747
CYCLINS AND CELL CYCLE CHECKPOINTS
Johnson, D. G., & Walker, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.295 · Cited by 719
PREVENT IV Investigators* (2005) · JAMA · doi:10.1001/jama.294.19.2446 · Cited by 656
Metadata
- Authors
- Morishita, R., Gibbons, G. H., Horiuchi, M., Ellison, K. E., Nakama, M., Zhang, L., Kaneda, Y., Ogihara, T., & Dzau, V. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-06-20
- Volume
- 92
- Issue
- 13
- Pages
- 5855-5859
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2007499397
- Cited by
- 479
- References
- 21
- FWCI
- 10.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.